Showing 10 of 10 recruiting trials for “epilepsy-with-myoclonic-atonic-seizures”
RecruitingNCT07251673 ↗
Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation
👨⚕️ Stéphane Auvin, MD, PhD, Assistance Publique Hopitaux de Paris📍 1 site📅 Started Sep 2025View details ↗
Harmony TPV EMEA PMS
👨⚕️ Peter Ewert, Prof. Dr., TUM Klinikum Deutsches Herzzentrum📍 12 sites📅 Started Jul 2025View details ↗
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
BMB-101 in Absence Epilepsy and DEE
Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
EXploring novEl Molecular Determinants of DRAvet Syndrome Phenotype Heterogeneity
🏥 Fondazione Policlinico Universitario Agostino Gemelli IRCCS📍 1 site📅 Started Jul 2023View details ↗
RecruitingNCT05651204 ↗
GABA Biomarkers in Dravet Syndrome
👨⚕️ Christos Papadelis, PhD, Cook Children's Health Care System📍 1 site📅 Started Sep 2022View details ↗
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →